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ABSTRACT
Objectives: To gain an understanding of the views of
women with false-positive screening mammograms of
screening recall services, their ideas for service
improvements and how these compare with current UK
guidelines.
Methods: Inductive qualitative content analysis of
semistructured interviews of 21 women who had
false-positive screening mammograms. These were
then compared with UK National Health Service (NHS)
guidelines.
Results: Participants’ concerns about mammography
screening recall services focused on issues of
communication and choice. Many of the issues raised
indicated that the 1998 NHS Breast Screening
Programme guidelines on improving the quality of
written information sent to women who are recalled,
had not been fully implemented. This included being
told a clear reason for recall, who may attend with
them, the length of appointment, who they will see and
what tests will be carried out. Additionally women
voiced a need for: reassurance that a swift appointment
did not imply they had cancer; choice about invasive
assessment or watchful waiting; the offer of a follow-
up mammogram for those uncertain about the validity
of their all-clear and an extension of the role of the
clinical nurse specialist, outlined in the 2012 NHS
Breast Screening Programme (NHSBSP) guidelines,
to include availability at the clinic after the all-clear for
women with false-positive mammograms.
Conclusions: It is time the NHSBSP 1998 recall
information guidelines were fully implemented.
Additionally, the further suggestions from this
research, including extending the role of the clinical
nurses from the 2012 NHSBSP guidelines, should be
considered. These actions have the potential to reduce
the anxiety of being recalled.
INTRODUCTION
Screening for breast cancer by mammog-
raphy has been part of many women’s
routine healthcare for more than 25 years.
Much research has been carried out into the
anxiety produced by having a false-positive
mammogram (FPM).1–6 However, the quality
of mammography screening services for
women who have been recalled has been less
thoroughly investigated. Internationally, ques-
tionnaire studies have found that overall
women are satisﬁed with the service they
receive.7–10 Additionally, some studies found
that the attitude of clinic staff as well as the
quality of information and the physical envir-
onment affected satisfaction.7 9–12
Furthermore, a Finnish observational study
that investigated the information needs of
women assessed by biopsy, found that women
wanted information and reassurance
throughout and after their assessment.11
However, a Canadian randomised controlled
trial failed to ﬁnd an impact on satisfaction
from additional information.13 The above
research gives an opaque picture of the infor-
mation and support needs of women
recalled following screening.
The situation in the UK is particularly
unclear as our searches found only one UK
study of service satisfaction of women with a
FPM. This was by Smith et al14 who found
that clinic staffs’ attitudes, quality of informa-
tion and the physical environment had an
impact on satisfaction. However, this survey is
Strengths and limitations of this study
▪ This research has been rigorously conducted by
an independent, academic research team.
▪ The suggestions for service improvements are
based on empirical research.
▪ The evidence provides current insights into
women’s view of mammography screening ser-
vices for recalled women.
▪ The study may be limited by the ability of some
participants to recall distant experiences.
▪ More detailed information about the demo-
graphic characteristics of participants would aid
interpretation of the results.
Bond M, et al. BMJ Open 2015;5:e005855. doi:10.1136/bmjopen-2014-005855 1
Open Access Research
more than 20 years old and it is 16 years since the NHS
Breast Screening Programme (NHSBSP) produced
guidelines about the information needs of women
recalled following mammography screening.15 More
recently NHSBSP guidelines (2012) highlight the
important role of the clinical nurse specialist (CNS) in
supporting women who have been recalled.16 As FPM
affects more than 50 000 women a year in England
alone, we were interested in women’s views of the
service they received, their thoughts on how they might
be improved and how these compared with NHSBSP
guidelines.
The research question is: What are the views of
women with false-positive screening mammograms of
the recall service they received, their ideas for service
improvements and how do these compare with existing
UK guidelines?
METHOD
We chose to use semistructured interviews because they
employ open-ended questions within the framework of
an interview guide, facilitating a discourse where the
interviewee is free to respond to the questions in a self-
directed way. This approach produces responses that are
rich in content and may contain interesting and relevant
material beyond the scope of the initial question.
Participants and recruitment
Fifty-two women with FPM were invited to participate
and 21 were recruited (40%). Recruitment was through
the National Institute for Health Research Primary Care
Research Network, from three local general practices or
through the University of Exeter staff e-newsletter.
Participants were purposively sampled for diversity of
age, time from the false-positive experience and type of
assessment procedure. We were also interested in the
social mix of participants and used the UK Index of
Multiple Deprivation (IMD), relating to their post code,
as a means of assessing this. The IMD is derived from a
national survey of income, employment, health, educa-
tion, housing, crime and living environment. The scores
are ranked from the least to the most deprived.17 Owing
to the speciﬁc focus of the research it was believed that
about 20 interviews would be sufﬁcient for data satur-
ation. If saturation did not occur further participants
would be recruited.18 Participants gave informed
consent.
Data collection
Participants were interviewed by MB in quiet locations of
their choosing, usually at home. The interview guide
(available from the authors) was used to gather key
pieces of information. It covered the experiences of
being invited for screening, being recalled, the assess-
ment clinic and reﬂections of that experience. The
guide was based on the results of the latest UK systematic
review1 and reviewed by two women with FPM. The
interviews were recorded and transcribed.
Data analysis
The interviews were analysed with inductive qualitative
content analysis.19 This approach was chosen because we
wanted to develop simple categories from the interviews
to compare with the items in the guidelines rather than
explore the deeper meanings of what the participants
were saying. This process involved reading and listening
to the interviews iteratively as relevant content was open
coded. The codes were reviewed across the manuscripts
by a process of constant comparison, being merged and
dropped as the analysis progressed. The codes were then
gathered into categories of similar items.20 These
primary categories were subsumed into higher order
generic categories and so assisted the systematic descrip-
tion of the phenomena, thus identifying the key mes-
sages in the texts.21
The results were validated using Yardley’s principles of
sensitivity to context, commitment and rigour, transpar-
ency and coherence and impact and importance, includ-
ing an audit trail and the search for disconﬁrming
cases22 and participant feedback. The analysis was sup-
ported by Atlas.ti V.6.2 software. The application of
Yardley’s principles can be seen in table 1.
RESULTS
Participants’ characteristics were found to fulﬁl the cri-
teria of diversity. However, more detailed information
about educational level, income and social group would
aid interpretation of the results, see table 2.
The interview study showed that overall; almost all par-
ticipants were satisﬁed with the mammography recall
service they received. However, as they presented their
stories a number of issues were raised for service
improvement. These issues concerned the recall letter,
the assessment clinic, choice and subsequent screening.
Participants’ quotes are identiﬁed by a pseudonym.
A diagram of the relationship between the categories
can be found in ﬁgure 1.
Recall letter information
Most women were satisﬁed with the quality of the recall
information they were sent. The information was repeat-
edly described as reassuring. Many participants latched
onto the positive messages of the letter and remem-
bered they had been told that most recalled women
were clear of breast cancer and they should not worry
about being called back.
Anne: The letter itself I think said something reassuring
like… ‘as a precaution we’re calling you back because,
there’s some anomaly, or something like that, on the
screen…’ and then it says … a large proportion of
women who are called for second screening don’t actu-
ally have anything, but it’s just a precautionary thing, so
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I mean all the time they’re kind of trying to put forward
the, sort of, positive angle on it.
However, there was considerable variation in what
women were told to expect; some were simply told they
would have another mammogram and others were given
an explanation about the reason for their recall.
Clare: In the letter, yeah, when I was recalled, they actu-
ally said … ‘we’d like you to come again, so we can take
some further x-rays,’ and they’ve also said ‘at this visit we
may also carry out an ultrasound examination’, so I was
aware of what was going to happen.
Moira: Only curious about what was going to happen,
because you don’t get told beforehand. You know you’re
going to have a mammogram, but you don’t know what
else is going to happen… so you’re not actually prepared.
Most of the women found the short time between the
recall letter and their assessment a positive thing as the
time of anxiety was curtailed:
Vicky: When I got the letter, to be recalled was only a few
days later, it wasn’t very long, which I’m really glad about.
I couldn’t have hung on two or three, four weeks, it was
a matter of days, it was very, very good, very good.
Conversely, others interpreted the quick appointment
as possibly indicating they had breast cancer. This under-
standing was rooted in a belief that the NHS only
responds quickly to serious health problems:
Grace: There wasn’t a lot of time, um, also between the
letter—I think it was about a week—between me getting
the letter and actually going for the, the next mammo-
gram, which tends to sort of go ‘oops,’ anything that
comes you don’t have much time in between means that
it could be serious.
Others who went alone found the waiting hardest as
they lacked the support of a friend or relative, but not
everyone knew they could bring someone with them.
Wendy: The only thing that I would have liked the letter
to have said was, ‘if you want to bring a friend or relative,
please do so.
These accounts indicate a variation in the amount and
content of the information that participants were given.
They also show that the information needs of these
women differed; some were able to focus on the positive
messages of the recall letter and were quite happy with
simply being told that although they were being recalled
Table 1 Yardley’s principles for quality in qualitative research
Principle Qualities Application to this study
Sensitivity to
context
Theoretical; relevant literature;
empirical data; sociocultural
setting; participant’s perspective;
ethical issues
Grounding the study in the context of what is already known from the
systematic review. Then gathering the new interview data to refine
that knowledge, searching for examples that confirm and refute what
is already known. Being aware of and sensitive to the sociocultural
place of the participants and how this might influence the meanings
they give to their experiences. Also understanding those experiences
from their perspective; what they meant to them, but acknowledging
the influence of the researcher and their role in the interview to what
is said through their demeanour, verbal and non-verbal cues and an
awareness of the potentially more powerful position of the researcher.
Ethical approval was gained
Commitment
and rigour
In-depth engagement with topic;
methodological competence; skill;
thorough data collection; depth/
breadth of analysis
This is achieved through becoming committed to the process of the
research, the integrity of the interviews, being emersed in the data
and taking a systematic, rigorous approach to the depth of analysis
and interpretation of the interviews. Accounting for the variety and
complexity of the data, including the search for disconfirming cases.
The trustworthiness of the analysis was further established by
respondent validation of the findings. The first eight interviews were
coded independently by two researchers
Transparency
and coherence
Clarity and power of description/
argument; transparent methods
and data presentation; fit between
theory and method; reflexivity
Providing a clear audit trail of the process of the study including data
analysis. Telling a clear coherent story that encompasses the range
of experience of the participants, illustrated by their own words and
offering a reflective interpretation of the meaning of their accounts that
acknowledges the role and influences of the researcher
Impact and
importance
Theoretical (enriching
understanding); sociocultural;
practical (for community,
policymakers, health workers)
Clearly describing the originality and importance of the findings and
how they relate to previous research. Demonstrating their importance
for policymakers, in this case the NHSBSP. Offering
recommendations to improve services to reduce the psychological
impact of false-positive mammograms
Source: Yardley (2000).
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everything was probably alright. Others reacted more
strongly to the uncertainty that was introduced into
their lives and wanted as much detail as possible about
the reasons for their recall; the implications of this and
what was going to happen at the assessment clinic.
At the clinic
Waiting generally provoked anxiety; one participant said
this could have been reduced by information about how
long the clinic appointment was likely to take:
Karen: The waiting was the worst…the whole thing was
bad, but the worst bit was having to wait and not knowing
how long I was waiting for.
Many participants reported that the clinic staff were
the best thing about their experience. They were repeat-
edly described as Rachel: lovely, Moira: friendly, Ella:
supportive, Zoe: kind, Anne: professional and Vicky:
very, very nice:
Zoe: They were just very kind and I think, in a way, nurt-
uring, because they knew there was a possibility that you
might have bad news. They were just very protective of
you; you just felt that they were handling it really well,
that they cared about you.
Clear explanations of the nature of the lesion were
valued and helped to bring peace amid the uncertainty.
Laura: He was ever so…really thorough, I’ve got to say,
really put my mind at rest … explained everything to me
from start to ﬁnish, … and did it in a way…not condes-
cending way, he explained it in a real clear and concise
manner, yeah, absolutely brilliant. I came out
cock-a-hoop!
Although the majority had positive encounters, not all
the staff were sensitive and caring.
Chloe: Um…yes, it didn’t feel quite friendly, the staff in
the unit sometimes…it was a case of, ‘oh, yeah,’ it’s just…
like the queue… ‘oh, right, yeah, next.
There was evidence of an unmet need for information
and reassurance that could have been given by a CNS
being available, and known to be available, after as well
as before assessment. This unavailability resulted in
some women leaving the clinic with uncertainty and
unanswered questions.
Laura: Don’t think so [someone to talk to]. Didn’t see…
there was a nurse, yes, there was a nurse on duty, but she
was very busy and I could see she was very busy.
Grace: I can’t recall there being anybody around.
Fran: Well, I suppose somebody to talk…you know,
perhaps if I’d gone and talked to somebody, you know,
about it all, perhaps I…it would have eased me.
During their assessment the amount of information
that participants wanted about their lesion varied.
A number of them would have had more conﬁdence in
their all-clear result if they had been given a clearer
explanation of what their lesion meant, including the
risk of it becoming malignant so they could make an
informed choice about how to proceed.
Liz: I would like the doctors to present me with the facts
and say ‘right, you know…if it’s 20 women out of…out of
100 with hyperplasia who, you know, before they die, so
they could be really old, get breast cancer,’ then I know
that fact. If it’s, um, you know, one in 10,000 up to the
age of 80, then I probably would opt not to have any
invasive surgery again.
One participant’s experience highlighted the need for
consistency between the messages from the clinical staff
and the literature they were given. The radiologist had
told her that her cysts could not become cancerous and
then gave her a leaﬂet that said they could; this caused
considerable anxiety. This inconsistency led her to
request an interim mammogram for reassurance from
her general practitioner (GP) but was turned down:
Moira: And I now wait for my next mammogram…but
that’s the bit I don’t like. You’re told you have cysts, but
Table 2 Summary of participants’ characteristics
Characteristics Women, N (%)
Age (years)
40–49 2 (10)
50–59 11 (52)
60–69 8 (38)
Marital status
Married or cohabiting 19 (90)
Single, separated or widowed 2 (10)
Ethnicity
White 21 (100)
Time since false-positive (years)
≤1 year 4 (19)
2–4 7 (33)
5–7 8 (38)
8–10 1 (5)
11–13 1 (5)
Type of assessment procedure*
Mammogram 16 (76)
Ultrasound 12 (57)
Fine needle aspiration 1 (5)
Biopsy 4 (19)
Index of Multiple Deprivation %
Unknown 4 (19)
0–9 1 (5)
10–19 0 (0)
20–29 2 (9)
30–39 3 (14)
40–49 2 (9)
50–59 4 (19)
60–69 4 (19)
70–79 1 (5)
*Many women had more than one assessment procedure.
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you’re not given a follow-up from there and you
should…I’m assuming that they’re quite satisﬁed that
they [cysts] cannot become cancerous, even though the
leaﬂet says they can. So I’m assuming they either haven’t
read the leaﬂet, or they simply don’t believe the leaﬂet,
I don’t know which.
While the women waited at the clinic it was apparent
that the location, layout and the waiting environment
played a role in moderating their experience. Some par-
ticipants had their initial screening in mobile units but
then went to a hospital for their assessment.
Zoe: Perhaps it seems more serious because you’re aware
it’s a place where there are sick people… whereas if you
go to the unit that goes to the car parks and whatever,
you’re in and out in ten minutes and you move on.
For some the physical layout of the clinic meant they
were aware of what was happening to other women
ahead of them in the queue; increasing their anxiety as
they waited.
Grace: We waited in a corridor … we, sort of, waited in a
long line, sat down in a long line … we all waited
together and we all went in and you’d see people go
through the door, but they also came out that door and
you knew if it was good or bad news for them, because
obviously if it was good news they were looking happy,
and if it was bad news they didn’t go straight down the
corridor, they went into another room. Um, and that
would have been, I think, pretty traumatic for anybody,
because you knew which way…but also for us, because we
knew if it was good or bad news for them. I remember
thinking, ‘well, I’m going to have to go through that in a
minute, but I don’t want to witness their distress either.
On other occasions the participants could not see the
woman diagnosed with breast cancer but they could
hear her crying, which similarly increased their anxiety.
Wendy: while I was waiting somebody else had…who had
been recalled, um, had been told that they, you know,
they did have something and obviously they were dis-
tressed and, you know, people waiting, that was distressing
as well…I could hear, I couldn’t see her, but I could hear
her and that was distressing, yes.
Although the staff received much praise, there was still
a clear need for an opportunity to talk to the CNS after
the all-clear if questions remained about the reliability
of the diagnosis and the probability of it becoming
malignant. The status of their lesion remained a
concern at the next screening round for some women
and information about if or how it had changed would
have been valued. The responses also showed that a sen-
sitivity to the clinical environment is necessary with due
regard for privacy.
Choice
Following their assessment a number of women were
uncertain about the validity of their all-clear diagnosis.
They would have liked the option of a follow-up mam-
mogram for reassurance.
Ella: I thought ‘can you just see me in a year’s time, just
tell me that in a year’s time, it’s all OK in a year’s time?
Figure 1 Category development.
Bond M, et al. BMJ Open 2015;5:e005855. doi:10.1136/bmjopen-2014-005855 5
Open Access
Zoe: I think the fact that you’ve been faced with the pos-
sibility that something didn’t look quite right, you’re not
quite sure what it was that didn’t look quite right, um,
and maybe a screening a year down the line would have
been, um, something to…to, you know, relieve any
nerves.
There was also a request for mammograms as an alter-
native to the invasive investigation of lesions by biopsy
that were thought to be almost certainly benign.
Liz: Because they said, ‘we’re pretty sure it isn’t anything,
but we need to check if it is anything.’ …and so I
suppose what I’m saying is that had there been a little bit
more, um, wait and see… I wouldn’t have had more
anxiety if they’d say, ‘well, we’ll do a mammogram again
in three months or six months.
This plea for choice was part of a desire to be more
involved in the decision-making process about how to
proceed once a lesion was detected. Many of the women
felt disempowered by the assessment process. They per-
ceived themselves to be Ella: ‘in the system’ and passive
partakers of assessment procedures.
Liz: I think when you’re in the middle of it, you just go
along with whatever’s being told… there could have
been, uh, more consultation maybe at the beginning of
things… so…and I’d have probably still have gone along
with it, [surgery] ‘cause I don’t think I felt empowered
not to.
Another woman would have appreciated the choice of
receiving her biopsy results by post or over the phone, as
this further wait prolonged anxiety.
Fran: It was just waiting for those results… every day you
look for the post… and when it’s there you’re frightened
to open it up…it [phone call] probably would have been
better, really, ‘cause you’re looking every day, aren’t you,
at the post and thinking, ‘oh, my gosh.’
It was clear that some women would have valued more
choice in the assessment process. Choice was requested
for follow-up mammograms to reduce uncertainty and
anxiety about the outcome of assessment, ‘watchful
waiting’ as an alternative to biopsy and test results over
the phone rather than through the post.
At the next screening round
At their next routine screening, some participants’ anx-
ieties would have been dispelled if they were told about
the status of the lesions previously discovered:
Jane: I just got the all-clear letter, sort of thing, [after sub-
sequent screening] and when I saw the doctor [GP] I
said ‘when I…you got the results of me mammogram did
it say anything about the cyst?’ And he looked it back
and he said, ‘no, it hasn’t said anything.’ And it would
have been just nice to know whether I’ve still got it or
not.
Comparison of these results with NHSBSP guidelines
Many of our ﬁndings echo those of the research used to
produce the NHSBSP 1998 guidelines and indicate that
these have not been universally implemented.23–25
A comparison of the NHSBSP guidelines with our service
improvement suggestions can be found in table 3.
The following suggestions are offered to improve
services.
Recall letter
Recall letters issued should be consistent and include
the following items. The ﬁrst ﬁve items remain unad-
dressed from the 1998 guidelines.
This should include
1. The reason for recall.
2. Who can come with them.
3. How long the appointment is likely to take.
4. Who they will see.
5. What tests will be carried out.
6. Where to get further information.
7. The availability of a CNS to answer questions before
and after assessment.
8. Reassurance that a swift appointment is normal and
does not indicate there is anything wrong.
At the clinic
9. A preassessment conversation with the CNS covering,
the reason for recall, the assessment process including
possible harms, and the availability of the CNS for a
debrief after the assessment whatever the outcome.
10. From the Radiologist at diagnosis; sufﬁcient time for
a clear explanation of the type of lesion, risk of it
becoming malignant, with clarity about uncertainty.
If a biopsy is advised then discussion about pros and
cons including the reliability of biopsy results and
the choice of watchful waiting if the lesion is almost
certainly benign.
11. The availability of CNS post-assessment to clarify the
diagnosis and provide reassurance, as a woman may
not feel able to question the outcome with her GP.
If the woman remains unsure of the validity of her
all-clear a follow-up mammogram should be
considered.
12. Literature about the type of lesion found should be
offered. This should agree with that from the
Radiologist and give a phone number for further
information.
13. The choice of receiving biopsy results by phone or
post.
14. A one-way system through the clinic so that women
do not have to have the outcome of their assessment
witnessed or witness other’s outcomes.
At the next screening round
15. Women should be given an update about their
lesion, whether it has gone, stayed the same or
grown larger, with an explanation of the
implications.
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DISCUSSION
While overall participants were satisﬁed with the service
they received, they raised a number of areas where it
could be improved. Many of the items in the 1998
NHSBSP guidelines remained outstanding. Some
women were still asking for more information in the
recall letter about: the reason for their recall; who could
come with them; how long the appointment might take;
who they would see and what would happen to them.
Some participants were also concerned that a swift
appointment implied that they had cancer. At the assess-
ment clinic a more explicit explanation of why their
lesion was benign and the risk of it becoming malignant
would have reduced anxiety, together with literature
about their type of lesion. The women also expressed
requests for more choice as some were left with doubt
about the validity of the outcome of the assessment and
would have appreciated an offer to have a follow-up
mammogram in a year’s time for reassurance and an
update on the status of their lesion at their next screen-
ing round. Others felt powerless and in ‘the system’
when faced with a biopsy; an alternative of ‘watchful
waiting’ for lesions that were almost certainly benign,
would have been valued and empowering. A choice of
having biopsy results by post or over the phone was also
requested. Additionally some participants would have
valued an opportunity to see the CNS after assessment
as well as before. Finally, the layout of the clinic precipi-
tated anxiety for some women while they were waiting,
as they were able to see and hear the distress of women
who had been diagnosed with cancer. There was no
apparent link between participants’ demographic
characteristics and the issues they raised.
The strengths of this study are that it was rigorously con-
ducted and provides current, in-depth insights into the
views of women, with FPMs of the assessment service they
received. Thus it provides valuable evidence of how these
services may be improved so that the anxiety associated
with having FPMs may be reduced. The inﬂuence of the
researcher (MB) is acknowledged, both from her manner,
verbal and non-verbal cues during the interview; there is
also the potential for social desirability effects.26 The ana-
lysis has been through the ﬁlter of the researcher’s particu-
lar understanding of the issues, including being someone
Table 3 Comparison of our suggestions with those of the 1998 and 2012 NHSBSP guidelines
NHSBSP Recall guidelines
(38) 1998 Bond et al service suggestions 2014
Recall letter
information
A clear reason for recall A clear reason for recall
Who can come with them Who can come with them
How long the appointment will
take
How long the appointment will take
Who they will see Who they will see
What tests will be carried out What tests will be carried out
Where they can get further
information
Reassurance that a swift appointment does not imply the presence
of cancer
How to get to the assessment
centre
How to change their
appointment
When the results will be
available
At the clinic NHSBSP CNS guidelines (29)
2012
Availability of a CNS before
assessment
Availability of a CNS before and after assessment
Clear explanation of why the lesion is benign with any risk of
change to malignancy
Literature about the type of lesion
One-way layout through the clinic
Choice The offer of a follow-up mammogram in a year for those needing
reassurance of their ‘all clear’
Choice between invasive assessment and ‘watchful waiting’ for
lesions almost certainly benign
Choice of hearing biopsy results by post or over the phone
At the next screening
round
Clarification of the status of the lesion found to be a false-positive
NHSBSP, National Health Service Breast Screening Programme.
Grey shading represents the items from the 1998 NHSBSP Guidelines that were found to be still outstanding in the interviews, ie the same
matters arose.
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who has not had mammography. This will have inﬂuenced
the way the interviews were interpreted, due to the lack of
ﬁrst-hand experience. Qualitative research is notably sub-
jective and is open to the charge that the results lack gen-
eralisability. However, although the study has a number of
limitations and further research is needed to establish the
UK national picture, we believe these results are reason-
ably robust, transferable and relevant for consideration in
policy development. This is because the interview ﬁndings
were validated using Yardley’s principles22 and by partici-
pant feedback of a lay summary of the results. The study is
limited by lack of demographic detail, the limited geo-
graphical area (Devon) and the possible unreliability of
the participants’ memories as these events occurred
between 6 months and 12 years previously that is, recall
bias.27 However, the consistency of our ﬁndings with previ-
ous research23–25 and other studies, which have shown a
positive association between the accuracy of long-term
recall and the traumatic impact of an event up to 21
years,28 29 give us conﬁdence in the reliability of our
results.
Internationally, questionnaire studies have also found
that overall women are satisﬁed with mammography
screening recall services.7–10 In the case of FPMs there is a
certain irony about this response as the women are satis-
ﬁed with a service that has made a mistake in recalling
them and may have caused them unnecessary anxiety.
Further evidence comes from the Danish interview study
by Lindberg et al30 which found women with FPMs were
grateful for the service which had brought their health
into question and caused them psychological distress.
Some studies found, in agreement with ours, that the atti-
tude of clinic staff as well as the quality of information and
the physical environment affected satisfaction.7 9 10 14 Our
ﬁndings also agree with the results from the US qualitative
study (2001), that some participants thought the informa-
tion they received was inadequate.12
Although our research comes from a limited geograph-
ical area, and other regions of the UK may have better
service provision, it implies that there is still some way to
go to provide women who are recalled after breast cancer
screening with a satisfactory service. There is a need for
consistency in the implementation of recommendations
and a mechanism for ensuring this occurs.
Service implications
These suggestions will require additional resources;
increased hours for the CNS and additional mammog-
raphy for those needing reassurance or choosing ‘watchful
waiting’. However, most of the suggestions can be imple-
mented at the lower cost of revising literature and giving
clearer explanations, which may mean that fewer women
are left with uncertainty and request on-going care.
CONCLUSION
It is time the NHSBSP 1998 recall information guide-
lines were fully implemented. Additionally, the further
suggestions from this research, including extending the
role of the CNS from the 2012 NHSBSP guidelines,
should be considered.
Further research is needed to establish whether the
1998 NHSBSP recommendations are in place nationally
and if the additional measures outlined in these service
recommendations are sought by women throughout
the UK.
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